AI assistant
RESMED INC — Director's Dealing 2011
Apr 6, 2011
65715_rns_2011-04-06_cc7cba61-7f83-4b09-b9e1-7cf91224d58d.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity ResMed Inc. (RMD) ABN 46 064 514 852
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Peter C. Farrell |
|---|---|
| Date of last notice | January 10, 2011 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | DirectIndirect in 3 Grantee Retained Annuity Trusts |
|---|---|
| Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. | Peter C. Farrell April 2010 Annuity TrustPeter C. Farrell July 2010 Annuity TrustPeter C. Farrell November 2010 AnnuityTrust |
| Date of change | April 2, 2011 (equivalent to US datedtransaction of April 1, 2011) |
| No. of securities held prior to change | 316,328 shares held directly;600,000 shares held indirectly by 3 GranteeRetained Annuity Trusts (post split);Stock Options – 1,794,320 |
| Class | Common Stock |
| Number acquired | |
| Number disposed | 196,683 shares returned (gifted) from indirectto direct shareholdings |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation | Estimated value of shares transferred (gifted)US$5,895,558 |
|---|---|
| No. of securities held after change | 513,011 shares held directly;3,317 shares – Peter C. Farrell April 2010Annuity Trust200,000 shares – Peter C. Farrell July 2010Annuity Trust200,000 shares – Peter C. Farrell November2010 Annuity Trust1,794,320 stock options |
| Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back | Gift represents distribution from the Peter C.Farrell April 2010 Annuity Trust (the “Trust”)to the Peter C. Farrell Family Trust. Per theterms of the Trust, 90% of the original valuewas to be transferred back to Dr. Farrell atthe end of the first year. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | |
| Name of registered holder(if issued securities) | |
| Date of change | |
| No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changed | |
| Interest acquired | |
| Interest disposed | |
| Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation | |
| Interest after change |
Part 3 –[+] Closed period
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
Were the interests in the securities or contracts No detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3